Recent studies have demonstrated that KIF20A is overexpressed in many malignant tumors, including gastric cancer, glioma, bladder cancer, breast cancer, and prostate cancer (Li et al., 2019; Shen et al., 2019). This evidence concerns the gene KIF20A and urinary bladder cancer.